|
English
|
正體中文
|
简体中文
|
0
|
|
???header.visitor??? :
50694555
???header.onlineuser??? :
223
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"raabe c"???jsp.browse.items-by-author.description???
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 臺大學術典藏 |
2021-05-02T03:49:12Z |
Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations
|
Chang G.-C.; Lam D.C.-L.; Tsai C.-M.; Chen Y.-M.; JIN-YUAN SHIH; Aggarwal S.; Wang S.; Kim S.-W.; Kim Y.-C.; Wahid I.; Li R.; Lim D.W.-T.; Sriuranpong V.; Chan R.T.-T.; Lorence R.M.; Carriere P.; Raabe C.; Cseh A.; Park K. |
| 中山醫學大學 |
2021 |
Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations
|
Chang, GC; Lam, DCL; Tsai, CM; Chen, YM; Shih, JY; Aggarwal, S; Wang, SH; Kim, SW; Kim, YC; Wahid, I; Li, RB; Lim, DWT; Sriuranpong, V; Chan, RTT; Lorence, RM; Carriere, P; Raabe, C; Cseh, A; Park, K |
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
